TipRanks
Go Ultimate55% OFF

Compare MeVis Medical Solutions (M3V) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:M3VMeVis Medical SolutionsEUR 20.20EUR 37.13M26.84-17.89%―Unlock the DE:M3V analyst price target with TipRanks PremiumDE:M3VUnlock the DE:M3V top-analyst price target with TipRanks Premium
DE:COPCompuGroup MedicalEUR 28.45EUR 1.50B43.4216.12%―Unlock the DE:COP analyst price target with TipRanks PremiumDE:M3V vs DE:COPUnlock the DE:COP top-analyst price target with TipRanks Premium
DE:DRW8Draegerwerk AG & Co. KGaAEUR 74.80EUR 1.64B11.2822.95%―Unlock the DE:DRW8 analyst price target with TipRanks PremiumDE:M3V vs DE:DRW8Unlock the DE:DRW8 top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 13.37EUR 832.23M16.63-20.44%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumDE:M3V vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 23.90EUR 273.51M-562.501.91%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumDE:M3V vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 43.52EUR 47.86B21.66-10.64%Strong BuyUnlock the DE:SHL analyst price target with TipRanks PremiumDE:M3V vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-40%-20%0%20%40%60%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:M3VMeVis Medical Solutions20.20-4.40-17.89%
DE:COPCompuGroup Medical28.454.3017.83%
DE:DRW8Draegerwerk AG & Co. KGaA75.0015.4826.00%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik13.47-2.92-17.84%
DE:SBSSTRATEC Biomedical23.951.777.97%
DE:SHLSiemens Healthineers AG43.40-4.27-8.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts